Centerra Gold (CG) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
29 Apr, 2026Executive summary
Q1 2026 production met plan with 68,001 oz gold and 14.2M lbs copper produced across operations, with Mount Milligan and Öksüt delivering strong operational and financial results and robust free cash flow.
Cash balance increased to $543M, supporting self-funded growth and $33M returned to shareholders via buybacks and dividends.
Key growth projects advanced on schedule: Kemess PEA published, Mount Milligan PFS delivered, and progress at Thompson Creek and Goldfield.
Financial highlights
Q1 2026 net earnings were $79.4M; adjusted net earnings reached $88.2M; revenue rose 62% YoY to $484.7M.
Adjusted EBITDA increased 124% to $169.7M; free cash flow surged 390% to $49M.
EPS was $0.40; adjusted EPS was $0.44.
Cash flow from operations totaled $120M; total liquidity was $943M as of March 31, 2026.
Gold production costs were $1,649/oz and AISC on by-product basis was $1,705/oz, both higher year-over-year.
Outlook and guidance
2026 gold production guidance: 250,000–280,000 oz; copper: 50–60M lbs.
Mount Milligan 2026 guidance: 140,000–155,000 oz gold, 50–60M lbs copper; gold production costs $1,450–$1,550/oz, AISC $1,200–$1,300/oz.
Öksüt 2026 guidance: 110,000–125,000 oz gold; gold production costs $1,650–$1,750/oz, AISC $1,850–$1,950/oz.
Thompson Creek restart remains on track for mid-2027 production; 2026 non-sustaining capital guidance $190–220M.
Goldfield and Thompson Creek on track for first production in late 2028 and mid-2027, respectively.
Latest events from Centerra Gold
- 2025 exceeded production and financial targets, advancing growth and delivering record returns.CG
Q4 202520 Feb 2026 - Strong balance sheet and discounted valuation support organic growth in gold, copper, and molybdenum.CG
Investor presentation20 Feb 2026 - Q2 2024 saw strong results, robust liquidity, and ongoing capital returns with steady guidance.CG
Q2 20242 Feb 2026 - Restart and ramp-up of US molybdenum assets target $472M NPV8% and 22% IRR by 2028.CG
Investor Update20 Jan 2026 - Strong Q3 cash flow, stable costs, and strategic project progress support 2024 targets.CG
Q3 202417 Jan 2026 - 2024 delivered robust cash flow; 2025 to focus on disciplined spending and project growth.CG
Q4 202421 Dec 2025 - All director nominees, auditor appointment, and executive compensation motions were approved.CG
AGM 202525 Nov 2025 - Q1 2025 saw strong cash flow, robust liquidity, and major project advances.CG
Q1 202524 Nov 2025 - Strong Q2 results, robust liquidity, and project advances offset by higher cost guidance.CG
Q2 202523 Nov 2025